Morning Headlines 10/22/15

Genetic Testing Company 23andMe Returns to Market

After a two-year hiatus, personal genome testing vendor 23andMe resumes offering direct-to-consumer reports on DNA-based risk for diseases like Alzheimer’s and cancer. 23andMe was shut down by the FDA in 2013 for marketing the service to consumers without approval.

Theranos Founder Elizabeth Holmes Attempts To Clear Up The Bad Blood With WSJ

Theranos CEO and Founder Elizabeth Holmes follows last week’s very public feuding with the Wall Street Journal by attending the WSJ Live conference this week, where she sat for an on-stage interview about the allegations being made about her company.

Sasse Will Block All HHS Nominees Until Feds Provide CO-OP Answers

Karen DeSalvo, MD will likely have to wait for her assistant secretary for health at HHS nomination to be confirmed, as US Senator Ben Sasse (R-NE) promises to block consideration until the administration addresses the high rate of failure for co-op insurance plans established under the ACA.

Former ONC policy chief Jodi Daniel heads to D.C. law firm

Jodi Daniel, JD, MPH has joined Washington DC law firm Crowell & Moring. She left her position as ONC’s policy director last month.